聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 22 分钟 1 秒 前

Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders

周二, 05/10/2016 - 15:34
EVANSTON, Ill., May 10, 2016 -- (Healthcare Sales & Marketing Network) -- Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate (NMDA) receptor for the treatment of challenging neurological disorders, today anno...
Biopharmaceuticals, Neurology, Venture Capital, Personnel
Aptinyx, N-methyl-D-aspartate

Medicure Announces Departure of President and Chief Operating Officer

周二, 05/10/2016 - 15:32
WINNIPEG, May 9, 2016 -- (Healthcare Sales & Marketing Network) - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company today announced that the employment agreement with President and Chief Operating Officer, Daws...
Biopharmaceuticals, Cardiology, Personnel
Medicure, AGGRASTAT, tirofiban

Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)

周一, 05/09/2016 - 17:49
Updated Label Includes Data Describing VIBATIV Use Against Concurrent Bacteremia in Approved Indications DUBLIN, IRELAND--(Healthcare Sales & Marketing Network) - Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "C...
Biopharmaceuticals, FDA
Theravance Biopharma, VIBATIV, telavancin

U.S. FDA Expands IMBRUVICA(R) (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients

周一, 05/09/2016 - 17:43
Update to the IMBRUVICA U.S. Prescribing Information includes overall survival data from RESONATETM-2 study show significant improvements in previously untreated CLL/SLL patients with IMBRUVICA compared to chemotherapy (chlorambucil) Label also includes...
Biopharmaceuticals, Oncology, FDA
AbbVie, IMBRUVICA, ibrutinib, chronic lymphocytic leukemia

Elite Pharmaceuticals to Present SequestOx(TM) Data at the American Pain Society 35th Annual Scientific Meeting

周一, 05/09/2016 - 17:40
NORTHVALE, N.J., May 09, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American Pain Society 35th Annual S...
Biopharmaceuticals, Drug Delivery
Elite Pharmaceuticals, SequestOx, oxycodone

Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer

周一, 05/09/2016 - 17:38
BALTIMORE, May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome testing products and services, today announced that Douglas Ward has joined the company as Chief Executive Of...
Diagnostics, Personalized Medicine, Personnel
Personal Genome Diagnostics, PGDx

Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs

周一, 05/09/2016 - 15:19
Appointment Reflects Company's Late-Stage Clinical Focus and Plans to Prepare for Commercialization ROCKVILLE, Md., May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on ...
Biopharmaceuticals, Gastroenterology, Personnel
Synthetic Biologics, gut microbiome, irritable bowel

Signostics Launches Uscan(TM) in Europe - the World's First Smart Mobile-connected Visualisation Device Specialised for Urologic Care

周一, 05/09/2016 - 13:21
Uscan provides urologic visualisation for efficient and more confident point-of-care clinical decision-making LONDON, May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Signostics, the global innovator in smart, high reliability ultrasound device...
Devices, Urology, Product Launch
Signostics , Uscan , ultrasound

Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids

周一, 05/09/2016 - 13:13
Phase III study met all co-primary and secondary endpoints and achieved statistically significant results DUBLIN and BUDAPEST, Hungary, May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan Plc (AGN) and Gedeon Richter Plc. today announced ...
Biopharmaceuticals
Allergan, Gedeon Richter, ulipristal, uterine fibroids

Epizyme Continues to Build Senior Leadership Team with Appointment of Matthew Ros as Chief Operating Officer

周五, 05/06/2016 - 14:23
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Epizyme, Inc. (EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, today announced that it has expanded its senior leadership team with the ...
Biopharmaceuticals, Oncology, Personnel
Epizyme, chromatin modifying proteins, tazemetostat

venBio Closes $315 Million Life Sciences Venture Capital Fund

周五, 05/06/2016 - 13:24
SAN FRANCISCO, May 6, 2016 -- (Healthcare Sales & Marketing Network) -- venBio Partners LLC, a global life sciences investment firm, today announced the closing of the venBio Global Strategic Fund II, its second life sciences venture capital fund, for a t...
Biopharmaceuticals, Venture Capital, Personnel
venBio Partners

Application of Fish Skin to Open Wounds Improves Healing

周五, 05/06/2016 - 13:18
High-Impact Trial Results of Fish Skin Wound Treatment Presented at Major European Wound Conference BREMEN, GERMANY--(Healthcare Sales & Marketing Network) - Kerecis, the company using Omega3-rich fish skin to heal human wounds and tissue damage, will p...
Regenerative Medicine, Wound Care
Kerecis , Omega3, fish skin

ACT Genomics Raises $12.5 Million In Series B Funding

周五, 05/06/2016 - 13:10
TAIPEI, Taiwan, May 6, 2016 -- (Healthcare Sales & Marketing Network) -- ACT Genomics, an integrated cancer molecular information company that transforms precision cancer care, today announced that the company has raised US$ 12.5 million in Series B fundi...
Diagnostics, Oncology, Venture Capital
ACT Genomics

TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging

周五, 05/06/2016 - 00:27
LipiScan™ ushers in a new era of routine assessment of meibomian gland health. Swift image capture empowers Eye Care Professionals (ECPs) to regularly view structure of meibomian glands MORRISVILLE, N.C., May 5, 2016 -- (Healthcare Sales & Marketing Net...
Devices, Ophthalmology, Product Launch
TearScience, LipiScan, LipiFlow, meibomian gland, dry eye

TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging

周四, 05/05/2016 - 17:33
LipiScan™ ushers in a new era of routine assessment of meibomian gland health. Swift image capture empowers Eye Care Professionals (ECPs) to regularly view structure of meibomian glands MORRISVILLE, N.C., May 5, 2016 -- (Healthcare Sales & Marketing Net...
Devices, Ophthalmology, Product Launch
TearScience, LipiScan, LipiFlow, meibomian gland, dry eye

Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales

周四, 05/05/2016 - 17:28
MALVERN, Pa., May 05, 2016 -- (Healthcare Sales & Marketing Network) -- Aclaris Therapeutics, Inc. (ACRS), a clinical-stage specialty pharmaceutical company, today announced that it has appointed Kevin Scott, an experienced sales executive within the field...
Biopharmaceuticals, Dermatology, Personnel
Aclaris Therapeutics

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong